Generic Drug Approval Process and Accessibility
Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the…
Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the…
Witnesses testified on drug company “pay-for-delay” deals, a ploy by to keep generic alternatives off the market. The…
Dr. Janet Woodcock testified at a hearing on the review and approval process for generic prescription drugs. She also…
Witnesses testified on the cost of HIV/AIDS medications and monopolies created in the HIV/AIDS drugs market. The focus…